title: [Perspectives of developing enzyme-based antitumor drugs].
authors.forename: V S
authors.initials: VS
authors.lastname: Pokrovskiĭ
authors.forename: N A
authors.initials: NA
authors.lastname: Lesnaia
authors.forename: E M
authors.initials: EM
authors.lastname: Treshchalina
authors.forename: E V
authors.initials: EV
authors.lastname: Lukasheva
authors.forename: T T
authors.initials: TT
authors.lastname: Berezov
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology*; D001120:Arginine / Q000378:metabolism; D001215:Asparaginase / Q000378:metabolism; D013437:Carbon-Sulfur Lyases / Q000378:metabolism; D015195:Drug Design; D004798:Enzymes / Q000378:metabolism*; D006801:Humans; D008239:Lysine / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism; D012260:Ribonucleases / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D004798:Enzymes; D001120:Arginine; D010088:Oxidoreductases; D012260:Ribonucleases; D001215:Asparaginase; D013437:Carbon-Sulfur Lyases; C021558:L-methionine gamma-lyase; D008239:Lysine